Neurosteer
Neurosteer50
About
What does Neurosteer do?
Neurosteer reinvents brain scanning with its novel hdrEEG™ technology, offering a medical-grade, pocket-sized device for real-time brain activity analysis. This platform provides objective biomarkers for the early detection and monitoring of neurological disorders like Parkinson's, Alzheimer's, and epilepsy, serving clinical trials and enabling continuous remote monitoring for improved neurological treatment.
What is Neurosteer's revenue?
StartupHub estimates Neurosteer's annual revenue at $2.0M (range $1.1M to $2.8M, 66% confidence), based on comparable companies in the sector.
What is Neurosteer's valuation?
StartupHub estimates Neurosteer's effective valuation at $3.9M (range $2.5M to $6.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Neurosteer raised?
Neurosteer has raised a total of $1M in funding. The most recent round on record is Seed.
Where is Neurosteer headquartered?
Neurosteer is headquartered in Tel Aviv, Israel.
When was Neurosteer founded?
Neurosteer was founded in 2015.
What industry does Neurosteer operate in?
Neurosteer operates in Healthcare, Neurology, Mental Health, Monitor, Brain, Neurotech.
How many employees does Neurosteer have?
Neurosteer has approximately 11 people on record.
No comments yet. Be the first to share your take.